Search

Author/Creator Meier, Friedegund

3. Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial. Issue 10358 (1st October 2022)

Authors:
Livingstone, Elisabeth; Zimmer, Lisa; Hassel, Jessica C; Fluck, Michael; Eigentler, Thomas K; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kiecker, Felix; Dippel, Edgar; Roesch, Alexander; Ziemer, Mirj...
Journal:
Lancet
Issue:
Volume 400:Issue 10358(2022)
Page Start:
1117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 10236 (16th May 2020)

Authors:
Zimmer, Lisa; Livingstone, Elisabeth; Hassel, Jessica C; Fluck, Michael; Eigentler, Thomas; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kieker, Felix; Dippel, Edgar; Rösch, Alexander; Simon, Jan-Chris...
Journal:
Lancet
Issue:
Volume 395:Issue 10236(2020)
Page Start:
1558
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Eggermont, Alexander M M; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A; Rutkowski, Piotr; Schadendorf, Dirk;...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Bottomley, Andrew; Coens, Corneel; Mierzynska, Justyna; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Puig, Susana; Ascierto, Paolo A; Larkin, James; Loriga...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery—the BUMPER study. Issue 1 (22nd October 2020)

Authors:
Amaral, Teresa; Niessner, Heike; Sinnberg, Tobias; Thomas, Ioannis; Meiwes, Andreas; Garbe, Claus; Garzarolli, Marlene; Rauschenberg, Ricarda; Eigentler, Thomas; Meier, Friedegund
Journal:
Neuro-oncology advances
Issue:
Volume 2:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG. Issue 4 (7th April 2023)

Authors:
Franklin, Cindy; Mohr, Peter; Bluhm, Leonie; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael; Kähler, Katharina; Grimmelmann, Imke; Gutzmer, Ralf; Utikal, Jochen; Terheyden, Patrick; Herbst, Rudolf; Haferkamp, Sebastian; Pfoehler, Claudia; Forschner, Andrea; Leiter, Ulrike; Ziller, F...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 4(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. Issue 2 (February 2020)

Authors:
Migden, Michael R; Khushalani, Nikhil I; Chang, Anne Lynn S; Lewis, Karl D; Schmults, Chrysalyne D; Hernandez-Aya, Leonel; Meier, Friedegund; Schadendorf, Dirk; Guminski, Alexander; Hauschild, Axel; Wong, Deborah J; Daniels, Gregory A; Berking, Carola; Jankovic, Vladimir; Stankevich, Elizabeth; B...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 2(2020)
Page Start:
294
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗